Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-UMIN000059241) titled 'A Multicenter Prospective Registry of Systemic Therapy for Unresectable Hepatocellular Carcinoma with Linked Multi-omics Biobanking and Translational Validation' on Oct. 1.
Study Type: Observational
Study Design:
Not selected Not selected
Primary Sponsor: The University of Osaka
Condition:
Hepatocellular Carcinoma
Recruitment Status: Recruiting
Phase: Not applicable
Date of First Enrollment: 2025/10/01
Target Sample Size: 1000
Countries of Recruitment:
Japan
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067756
Published by HT Digital Content Services ...